Engineered protease-resistant antibodies with selectable cell-killing functions.
about
HER2-family signalling mechanisms, clinical implications and targeting in breast cancer.An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.Current progress in innovative engineered antibodies.Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CATumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function.9th annual European Antibody Congress, November 11-13, 2013, Geneva, Switzerland.Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo.
P2860
Q38301236-E6991601-F81A-4473-9DED-7A3F32429E7FQ38880179-F2ED52E2-18C0-4300-9054-2D6E98391E7BQ38927756-3865DE04-344B-44F2-9640-F84CF829B052Q40077818-BA34D6B0-0A31-4C5C-B0DE-AD264D1B5538Q42557137-BCE83C48-8BC7-4B52-96E2-637FC30439F1Q42577749-84F416D5-6A61-4AB4-91B9-C23A7772948EQ51238255-5FE1FF36-BE0C-4C0F-92D3-3C9994041218Q55015029-8B27679D-0A4E-4149-B6D9-60E0B166591E
P2860
Engineered protease-resistant antibodies with selectable cell-killing functions.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Engineered protease-resistant antibodies with selectable cell-killing functions.
@en
Engineered protease-resistant antibodies with selectable cell-killing functions.
@nl
type
label
Engineered protease-resistant antibodies with selectable cell-killing functions.
@en
Engineered protease-resistant antibodies with selectable cell-killing functions.
@nl
prefLabel
Engineered protease-resistant antibodies with selectable cell-killing functions.
@en
Engineered protease-resistant antibodies with selectable cell-killing functions.
@nl
P2093
P2860
P356
P1476
Engineered protease-resistant antibodies with selectable cell-killing functions.
@en
P2093
Frank Lynch
Gregory Bannish
Katharine A Heeringa
Katharine D Grugan
Keri L Soring
Meredith Perpetua
Michelle Kinder
Robert E Jordan
Stephen G McCarthy
William R Strohl
P2860
P304
30843-30854
P356
10.1074/JBC.M113.486142
P407
P577
2013-08-28T00:00:00Z